Helsinn launches new venture fund

Helsinn Group launched a new venture fund, Helsinn Investment Fund, with $50 million.

The fund will invest in companies that have technologies and assets in areas such as cancer therapeutics and diagnostics, cancer supportive care, metabolic and GI disorders, and dermatology. Helsinn said it is targeting companies with at least preclinical proof of concept, and "ideally" those with clinical data. ...